Mushroom Behind 'Tiny Human' Visions Lacks Genes For Known Psychedelics

This discovery highlights the ongoing advancements in genetic research and biotechnology, emphasizing the potential for developing novel, non-psychedelic compounds for medical or recreational use. It also underscores the importance of understanding the genetic makeup of organisms involved in producing psychoactive substances, which can impact drug development and regulation. For consumers, this could mean safer, more targeted therapies and a better grasp of the substances they encounter.

• The mushroom lacks genes for known psychedelics, indicating potential for non-psychoactive applications.
• Genetic insights can lead to safer, more controlled drug development.
• Understanding organism genetics helps inform regulation and public health policies.